CEO: | Mark Crossley |
CFO & Executive Director: | Ryan Preblick |
Chairman: | Graham Hetherington |
Independent Non-Executive Director: | Peter Bains |
Independent Non-Executive Director: | Barbara Ryan |
Independent Non-Executive Director: | Jo Le Couilliard |
Independent Non-Executive Director: | Keith Humphreys |
Independent Non-Executive Director: | Mark Stejbach |
Independent Non-Executive Director: | David E. Wheadon |
Senior Independent Director: | Juliet Thompson |
Non-Executive Dir: | Jerome Lande |
Address: | 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE |
Website: | http://www.Indivior.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE 250, FTSE 350, FTSE All-Share |
Overseas Listings: | BATSLON:INDVL |
ISIN: | GB00BN4HT335 |
Currency | UK Pounds |
Share Price | 987.00p |
Change Today | 25.50p |
% Change | 2.65 % |
52 Week High | 1,885.00p |
52 Week Low | 756.50p |
Volume | 971,875 |
Shares Issued | 133.79m |
Market Cap | £1,320.49m |
RiskGrade | 314 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
16:35 | 900 @ 987.00p |
16:35 | 2,193 @ 987.00p |
16:35 | 1 @ 987.00p |
16:35 | 366,393 @ 987.00p |
16:35 | 122 @ 987.00p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research